CDEK
← All organizations
Contura

Contura

For profitContributed to NMEWebsite ↗

Also known as: Speciality European | SPECIALITY EUROPEAN

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 1999

First marketed drug

Nov 25, 2003

Last known activity

Nov 25, 2003

Acquired by Axonics on Mar 1, 2021

Timeline

1990s

  1. Jun 1, 1996

    Contura— Founded

2000s

  1. Nov 25, 2003

    abarelix— NDA Secondary Org

  2. Jan 1, 2009

    Contura— Defunct

2020s

  1. Mar 1, 2021

    Axonics— Acquired By

Drugs by trial phase (3 distinct, 1 trials)

Phase 3 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (1)

Details

Founded
London, GB Jun 1, 1996
Last known activity
Nov 25, 2003